Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
  1. 4 Open-market sale EVP and Chief Medical Officer sold 2,821 shares at $66.62 ($187,935)
  2. 4 Shares withheld for taxes President & CEO gave up 12,162 shares (to pay taxes)
  3. 5 Insider Annual Insider Trading Report
  4. 5 Insider Annual Insider Trading Report
  5. 4 Open-market sale EVP and Chief Medical Officer sold 1,657 shares at $66.30 ($109,859)
  6. 4 Open-market sale EVP and Chief Medical Officer sold 359 shares at $81.14 ($29,129)
  7. 4 Open-market sale EVP & Chief Commercial Officer sold 303 shares at $81.14 ($24,585)
  8. 4 Open-market sale EVP & Chief Tech Ops Officer sold 358 shares at $81.14 ($29,048)
  9. 4 Open-market sale SVP, Chief Accounting Officer sold 140 shares at $81.14 ($11,360)
  10. 4 Open-market sale CBO & EVP sold 286 shares at $81.14 ($23,206)
  11. 4 Open-market sale EVP and General Counsel sold 310 shares at $81.14 ($25,153)
  12. 4 Shares withheld for taxes President & CEO gave up 853 shares (to pay taxes)
  13. 4 Open-market sale Pinion John Richard sold 358 shares at $81.14 ($29,048)
  14. 4 Open-market sale CFO & Executive Vice President sold 6,738 shares at an average $82.00 ($552,524)
  15. 4 Exercise or conversion CBO & EVP acquired 109,734 shares (option exercise)
  16. 4 Open-market sale EVP and General Counsel sold 7,336 shares at $100.65 ($738,368)
  17. 4 Open-market sale EVP and Chief Medical Officer sold 5,000 shares at an average $100.11 ($500,525)
  18. 4 Open-market sale Director sold 800,000 shares at an average $54.54 ($43,631,250)
  19. 4 Open-market sale EVP & Chief Commercial Officer sold 375 shares at $91.53 ($34,324)
  20. 4 Grant or award Director acquired 3,895 shares (grant or award)

Page 9 of 32 · 627 filings